Literature DB >> 12508283

The viral control of cellular acetylation signaling.

Cécile Caron1, Edwige Col, Saadi Khochbin.   

Abstract

It is becoming clear that the post-translational modification of histone and non-histone proteins by acetylation is part of an important cellular signaling process controlling a wide variety of functions in both the nucleus and the cytoplasm. Recent investigations designate this signaling pathway as one of the primary targets of viral proteins after infection. Indeed, specific viral proteins have acquired the capacity to interact with cellular acetyltransferases (HATs) and deacetylases (HDACs) and consequently to disrupt normal acetylation signaling pathways, thereby affecting viral and cellular gene expression. Here we review the targeting of cellular HATs and HDACs by viral proteins and highlight different strategies adopted by viruses to control cellular acetylation signaling and to accomplish their life cycle. Copyright 2002 Wiley Periodicals, Inc.

Mesh:

Substances:

Year:  2003        PMID: 12508283     DOI: 10.1002/bies.10202

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  23 in total

Review 1.  Regulating histone acetyltransferases and deacetylases.

Authors:  Gaëlle Legube; Didier Trouche
Journal:  EMBO Rep       Date:  2003-10       Impact factor: 8.807

2.  HIV-1 Tat targets Tip60 to impair the apoptotic cell response to genotoxic stresses.

Authors:  Edwige Col; Cécile Caron; Christine Chable-Bessia; Gaelle Legube; Sylvie Gazzeri; Yasuhiko Komatsu; Minoru Yoshida; Monsef Benkirane; Didier Trouche; Saadi Khochbin
Journal:  EMBO J       Date:  2005-07-07       Impact factor: 11.598

3.  Transcription of subgenomic mRNA of hepatitis delta virus requires a modified hepatitis delta antigen that is distinct from antigenomic RNA synthesis.

Authors:  Chung-Hsin Tseng; King-Song Jeng; Michael M C Lai
Journal:  J Virol       Date:  2008-07-23       Impact factor: 5.103

4.  Sirtuin 2 Isoform 1 Enhances Hepatitis B Virus RNA Transcription and DNA Synthesis through the AKT/GSK-3β/β-Catenin Signaling Pathway.

Authors:  Zahra Zahid Piracha; Hyeonjoong Kwon; Umar Saeed; Jumi Kim; Jaesung Jung; Yong-Joon Chwae; Sun Park; Ho-Joon Shin; Kyongmin Kim
Journal:  J Virol       Date:  2018-10-12       Impact factor: 5.103

5.  Regulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins.

Authors:  Yan Desfosses; Mayra Solis; Qiang Sun; Nathalie Grandvaux; Carine Van Lint; Arsene Burny; Anne Gatignol; Mark A Wainberg; Rongtuan Lin; John Hiscott
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  p53 targets simian virus 40 large T antigen for acetylation by CBP.

Authors:  Danielle L Poulin; Andrew L Kung; James A DeCaprio
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

7.  Proteomic studies reveal coordinated changes in T-cell expression patterns upon infection with human immunodeficiency virus type 1.

Authors:  Jeffrey H Ringrose; Rienk E Jeeninga; Ben Berkhout; Dave Speijer
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

8.  Functional interaction between class II histone deacetylases and ICP0 of herpes simplex virus type 1.

Authors:  Patrick Lomonte; Joëlle Thomas; Pascale Texier; Cécile Caron; Saadi Khochbin; Alberto L Epstein
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

Review 9.  Manipulation of the host protein acetylation network by human immunodeficiency virus type 1.

Authors:  Mark Y Jeng; Ibraheem Ali; Melanie Ott
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-09-02       Impact factor: 8.250

10.  HCMV IE2-mediated inhibition of HAT activity downregulates p53 function.

Authors:  Chih-Hung Hsu; Margaret D T Chang; Kang-Yu Tai; Yu-Ting Yang; Pei-Shan Wang; Chi-Ju Chen; Yan-Hsiung Wang; Sheng-Chung Lee; Cheng-Wen Wu; Li-Jung Juan
Journal:  EMBO J       Date:  2004-05-13       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.